Home -
Products -
Others -
Other Targets -
PAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base)
PAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base)
CAS No. ——
PAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base)( —— )
Catalog No. M22901 CAS No. ——
PAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 359 | In Stock |
|
| 10MG | 599 | In Stock |
|
| 25MG | 952 | In Stock |
|
| 50MG | 1458 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePAR-4 Agonist Peptide, amide(2TFA) 352017-71-1(free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
-
DescriptionPAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPAR-4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight908.84
-
Molecular FormulaC38H50F6N8O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C(F)(F)F.OC1=CC=C(C[C@H](NC([C@@H](N)C)=O)C(N2CCC[C@H]2C(NCC(N[C@@H](CCCCN)C(N[C@@H](CC3=CC=CC=C3)C(N)=O)=O)=O)=O)=O)C=C1.O=C(O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
trans-Isoferulic aci...
Isoferulic acid is an effective natural antioxidant in both lipid and aqueous media, it may be a new promising anti-glycation agent for the prevention of diabetic complications via inhibition of advanced glycation end products (AGEs) formation and oxidation-dependent protein damage.
-
Uprosertib
Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.
-
Neoanhydropodophyllo...
Neoanhydropodophyllol is a cyclolignan derivative, with antineoplastic activity. Neoanhydropodophyllol displays cytotoxicity against several cancer cells (leukemia, lung carcinoma and colon carcinoma).
Cart
sales@molnova.com